SECTORAL ASSET MANAGEMENT INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2020$618,000
-87.7%
26,700
-67.5%
0.06%
-89.3%
Q3 2018$5,015,000
+39.5%
82,263
+11.7%
0.53%
+32.3%
Q2 2018$3,595,000
-65.8%
73,614
-25.6%
0.40%
-65.1%
Q1 2018$10,511,000
+49.4%
98,914
-16.0%
1.15%
+31.1%
Q4 2017$7,036,000
+3920.6%
117,815
+823.3%
0.88%
+10887.5%
Q1 2016$175,000
-92.4%
12,760
-90.7%
0.01%
-91.9%
Q4 2015$2,311,000
+102.0%
137,127
+31.3%
0.10%
+90.4%
Q3 2015$1,144,000
-8.4%
104,399
+4.6%
0.05%0.0%
Q2 2015$1,249,000
+43.6%
99,852
+26.2%
0.05%
+57.6%
Q1 2015$870,00079,1150.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders